DRISCOLL JOSEPH 4
4 · Akoya Biosciences, Inc. · Filed Mar 25, 2022
Insider Transaction Report
Form 4
DRISCOLL JOSEPH
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-03-23+25,000→ 25,000 totalExercise: $11.88Exp: 2032-03-23→ Common Stock (25,000 underlying) - Award
Common Stock
2022-03-23+12,500→ 12,500 total
Footnotes (3)
- [F1]The restricted stock units shall vest in four (4) equal annual installments beginning on the first anniversary of the grant date and on each anniversary thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
- [F3]The options shall vest as follows: twenty-five percent (25%) shall vest on the first anniversary of the grant date with the remainder vesting in 36 equal monthly installments beginning on April 23, 2023.